Tenderwize
Back to tender search

Open House Original Discount Contracts 2025-17 - Beclometason, Formoterol, Glycopyrronium (ATC: R03AL09)

Techniker Krankenkasse·Hamburg, Germany·Deadline Jun 29, 2027 · 314 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-17 - Beclometason, Formoterol, Glycopyrronium (Wirkstoffkombination) ATC: R03AL09

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

50 / 100

Complexity

30 / 100

Risk factors

No estimated contract value provided; potential revenue cannot be assessed.

Contract terminates automatically upon patent expiry or loss of market exclusivity, which could shorten contract durati...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Jun 2027
  • Supply of pharmaceutical products containing active ingredient combination Beclometason, Formoterol, Glycopyrronium (ATC: R03AL09)
  • Nationwide delivery in Germany
Show full summary

Open House procedure (non-procurement) by Techniker Krankenkasse and associated health insurers for discount contracts (Rabattverträge) for the active ingredient combination Beclometason, Formoterol, Glycopyrronium (ATC: R03AL09). The contract is a supply of pharmaceutical products. No estimated value provided. Contract duration max 24 months from 01.07.2025 to 30.06.2027. Participation possible anytime during the contract period. Submission by email (with qualified electronic signature) or post. No exclusivity.

Risks

No estimated contract value provided; potential revenue cannot be assessed.

Contract terminates automatically upon patent expiry or loss of market exclusivity, which could shorten contract durati...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) as per §4 Abs. 18 AMG
  • Must hold a valid marketing authorization for the specific drug combination or be entitled to market it

Eligibility

  • Must submit a self-declaration (Anlage 4) confirming eligibility and reliability

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria specified; all qualified participants are accepted.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open House Original Discount Contracts 2025-17 - Beclometason, Formoterol, Glycopyrronium (ATC: R03AL09)

Discount contracts for the active ingredient combination Beclometason, Formoterol, Glycopyrronium (ATC: R03AL09) nationwide in Germany.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Jun 2025 - Jun 2027

Category

Pharmaceutical products

Award Criteria

No award criteria specified; all qualified participants are accepted.

Deadline

Deadline Jun 29, 2027

Procurement Details

Publication date
22 May 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
332579-2025

Documents (1)

Similar tenders